Medications in type-2 diabetics and their association with liver fibrosis

doi:10.3748/wjg.v26.i23.3249

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6018)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

512

WORD

156

HTML

3525

Figures (1-1)

197

Tables (1-3)

170

Sum=4560

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

590

Download

868

Sum=1458

Jun 21, 2020 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jun 21, 2020; 26(23): 3249-3259
Published online Jun 21, 2020. doi: 10.3748/wjg.v26.i23.3249

Open in New Tab Full Size Figure Download Figure

Figure 1 Graphical presentation of differences in medication usage among patients in different fibrosis groups.

Citation: Siddiqui MT, Amin H, Garg R, Chadalavada P, Al-Yaman W, Lopez R, Singh A. Medications in type-2 diabetics and their association with liver fibrosis. World J Gastroenterol 2020; 26(23): 3249-3259
URL: https://www.wjgnet.com/1007-9327/full/v26/i23/3249.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i23.3249